Galectin Therapeutics Inc (NASDAQ:GALT)

4.34
Delayed Data
As of Feb 16
 +0.34 / +8.50%
Today’s Change
1.28
Today|||52-Week Range
6.74
+29.94%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close4.00
Today’s open4.02
Day’s range3.91 - 4.35
Volume418,751
Average volume (3 months)792,510
Market cap$154.7M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+32.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book46.79

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc0.000.00%
TRILTrillium Therapeutic...-0.15-2.04%
VRMLVermillion Inc+0.03+2.08%
IDXGInterpace Diagnostic...-0.01-1.03%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts